Position in CPRX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$51,746,072
+$7,148,771 QoQ
Shares Held
2,089,906
+9.4% QoQ
Ownership
1.71%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ROYCE & ASSOCIATES LP holds $280,717,366 across 29 Biotechnology names. CPRX ranks #1 (18.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
2,089,906 | $51,746,072 | |
| 2 | TECH |
BIO-TECHNE Corp
|
759,712 | $39,702,549 | |
| 3 | INVA |
Innoviva, Inc.
|
1,061,448 | $24,731,738 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
232,923 | $17,296,861 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
94,017 | $15,890,753 | |
| 6 | ORIC |
Oric Pharmaceuticals, Inc.
|
1,207,223 | $15,295,515 | |
| 7 | CRMD |
CorMedix Inc.
|
1,887,532 | $12,816,342 | |
| 8 | CNTA |
Centessa Pharmaceuticals plc
|
278,064 | $11,044,702 |
All Filings in CPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $51,746,072 | 2,089,906 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $44,597,301 | 1,910,767 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $40,088,810 | 2,034,965 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $34,348,105 | 1,582,862 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $38,760,230 | 1,598,360 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $38,909,005 | 1,864,351 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $40,179,567 | 2,021,105 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $33,489,720 | 2,162,022 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $33,219,167 | 2,084,013 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $29,301,073 | 1,743,074 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $18,840,796 | 1,611,702 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $13,977,438 | 1,039,988 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $10,212,749 | 615,968 | Shares | Sole | 2023-05-23 | |
| 2022-12-31 | $9,893,135 | 531,889 | Shares | Sole | 2023-05-23 | |
| 2022-09-30 | $8,449,158 | 658,547 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $14,722,577 | 2,100,225 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $18,751,209 | 2,261,907 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $17,492,786 | 2,583,868 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $15,937,068 | 3,006,994 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $17,674,614 | 3,073,846 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $14,980,886 | 3,249,650 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $8,033,130 | 2,405,129 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $5,301,123 | 1,784,890 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $6,051,765 | 1,309,906 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,479,365 | 643,991 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||